European Pharmacopoeia reactivates plans to phase out mouse test for botulinum toxin testing
Industry News

European Pharmacopoeia reactivates plans to phase out mouse test for botulinum toxin testing

The European Pharmacopoeia has reactivated plans to phase out the mouse LD50 test for botulinum toxin, with cell-based alternatives offering a potential replacement.

Read More

Business News and Insights For Aesthetics Clinics and Practicitioners

Have all the latest news delivered to your inbox

Sign up
You must be a member to save and like images from the gallery.